NASDAQ:VMD - Nasdaq - CA92663R1055 - Common Stock - Currency: USD
7.78
-0.19 (-2.38%)
The current stock price of VMD is 7.78 USD. In the past month the price decreased by -6.83%. In the past year, price decreased by -9.43%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CI | THE CIGNA GROUP | 10.97 | 82.08B | ||
CVS | CVS HEALTH CORP | 11.71 | 79.88B | ||
LH | LABCORP HOLDINGS INC | 17.15 | 20.84B | ||
DGX | QUEST DIAGNOSTICS INC | 19.1 | 19.12B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 13.74 | 13.55B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 148.77 | 12.18B | ||
DVA | DAVITA INC | 14.99 | 11.68B | ||
HIMS | HIMS & HERS HEALTH INC | 112 | 10.77B | ||
CHE | CHEMED CORP | 23.84 | 8.18B | ||
CRVL | CORVEL CORP | 25.97 | 5.57B | ||
OPCH | OPTION CARE HEALTH INC | 26.89 | 5.45B | ||
GH | GUARDANT HEALTH INC | N/A | 5.30B |
Viemed Healthcare, Inc. engages in the provision of home healthcare solutions. The company is headquartered in Lafayette, Louisiana and currently employs 996 full-time employees. The company went IPO on 2017-12-22. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The firm provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).
VIEMED HEALTHCARE INC
625 E. Kaliste Saloom Rd.
Lafayette LOUISIANA 70508 US
CEO: Casey Hoyt
Employees: 1121
Company Website: https://www.viemed.com/
Investor Relations: https://www.viemed.com/investors/
Phone: 13375043802
The current stock price of VMD is 7.78 USD. The price decreased by -2.38% in the last trading session.
The exchange symbol of VIEMED HEALTHCARE INC is VMD and it is listed on the Nasdaq exchange.
VMD stock is listed on the Nasdaq exchange.
7 analysts have analysed VMD and the average price target is 13.09 USD. This implies a price increase of 68.25% is expected in the next year compared to the current price of 7.78. Check the VIEMED HEALTHCARE INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
VIEMED HEALTHCARE INC (VMD) has a market capitalization of 302.95M USD. This makes VMD a Small Cap stock.
VIEMED HEALTHCARE INC (VMD) currently has 1121 employees.
VIEMED HEALTHCARE INC (VMD) has a support level at 7.77 and a resistance level at 8.08. Check the full technical report for a detailed analysis of VMD support and resistance levels.
The Revenue of VIEMED HEALTHCARE INC (VMD) is expected to grow by 22.78% in the next year. Check the estimates tab for more information on the VMD EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
VMD does not pay a dividend.
VIEMED HEALTHCARE INC (VMD) will report earnings on 2025-02-26, after the market close.
The PE ratio for VIEMED HEALTHCARE INC (VMD) is 28.81. This is based on the reported non-GAAP earnings per share of 0.27 and the current share price of 7.78 USD. Check the full fundamental report for a full analysis of the valuation metrics for VMD.
The outstanding short interest for VIEMED HEALTHCARE INC (VMD) is 0.9% of its float. Check the ownership tab for more information on the VMD short interest.
ChartMill assigns a fundamental rating of 6 / 10 to VMD. While VMD has a great profitability rating, there are some minor concerns on its financial health.
Over the last trailing twelve months VMD reported a non-GAAP Earnings per Share(EPS) of 0.27. The EPS increased by 17.39% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 4.87% | ||
ROA | 6.15% | ||
ROE | 8.34% | ||
Debt/Equity | 0.05 |
ChartMill assigns a Buy % Consensus number of 80% to VMD. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 8.77% and a revenue growth 22.78% for VMD